-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$19.50315.78% Upside
Portage Biotech Inc. Frequently Asked Questions
-
What analysts cover Portage Biotech Inc.?
Portage Biotech Inc. has been rated by research analysts at H.C. Wainwright, Oppenheimer in the past 90 days.